Saturday, June 20, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 405 of 1,261
  1. US 10745680

    Factor IX fusion proteins and methods of making and using same

    BIOVERATIV THERAPEUTICS INC. · Granted Aug 18, 2020 · Expires Aug 13, 2040

    granted
  2. US 10745481

    Anti-CD166 antibodies, activatable anti-CD166 antibodies, and methods of use thereof

    CytomX Therapeutics, Inc. · Granted Aug 18, 2020 · Expires Aug 13, 2040

    granted
  3. US 10745665

    Nucleic acid molecules encoding an engineered antigen receptor and an inhibitory nucleic acid molecule and methods of use thereof

    Precision BioSciences, Inc. · Granted Aug 18, 2020 · Expires Aug 13, 2040

    granted
  4. US 10745702

    Compositions and methods for inhibiting expression of the LECT2 gene

    Alnylam Pharmaceuticals, Inc. · Granted Aug 18, 2020 · Expires Aug 13, 2040

    granted
  5. US 10746738

    Claudin-1 peptide reagents and methods

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Aug 18, 2020 · Expires Aug 13, 2040

    granted
  6. US 10736864

    Immunotherapeutic agent

    The Regents of the University of Colorado, a Body Corporate · Granted Aug 11, 2020 · Expires Aug 6, 2040

    granted
  7. US 10738130

    Bispecific antigen-binding molecules that bind MUC16 and CD3, and compositions thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Aug 11, 2020 · Expires Aug 6, 2040

    granted
  8. US 10738361

    Methods of predicting clinical course and treating multiple sclerosis

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Aug 11, 2020 · Expires Aug 6, 2040

    granted
  9. US 10738126

    Anti-GITR antibodies and uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Aug 11, 2020 · Expires Aug 6, 2040

    granted
  10. US 10738124

    Anti-EGFRvIII antibodies and uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Aug 11, 2020 · Expires Aug 6, 2040

    granted
  11. US 10738116

    Dual specific anti-CD22-anti-CD19 chimeric antigen receptors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 11, 2020 · Expires Aug 6, 2040

    granted
  12. US 10738081

    Peptide with anti-obesity and anti-diabetes activity and use thereof

    CAREGEN CO., LTD. · Granted Aug 11, 2020 · Expires Aug 6, 2040

    granted
  13. US 10738093

    Discovery of cationic nonribosomal peptides as Gram-negative antibiotics through global genome mining

    China Ocean Mineral Resources R&D Association · Granted Aug 11, 2020 · Expires Aug 6, 2040

    granted
  14. US 10738047

    Iodonium analogs as inhibitors of NADPH oxidases and other flavin dehydrogenases; formulations thereof; and uses thereof

    The United States of America, as represented by the Secretary, Department of Health · Granted Aug 11, 2020 · Expires Aug 6, 2040

    granted
  15. US 10738046

    Substituted pyrido[3,4-b]pyrazines as GPR6 modulators

    Takeda Pharmaceutical Company Limited · Granted Aug 11, 2020 · Expires Aug 6, 2040

    granted
  16. US 10738036

    Deuterated CFTR modulators

    Vertex Pharmaceuticals (Europe) Limited · Granted Aug 11, 2020 · Expires Aug 6, 2040

    granted
  17. US 10738014

    2-substituted amino-naphth (1,2-d) imidazol-5-one compounds or pharmaceutically acceptable salts thereof

    PTC THERAPEUTICS, INC. · Granted Aug 11, 2020 · Expires Aug 6, 2040

    granted
  18. US 10738010

    Process for preparing [(3-hydroxypyridine-2-carbonyl)amino] alkanoic acids, esters and amides

    Akebia Therapeutics, Inc. · Granted Aug 11, 2020 · Expires Aug 6, 2040

    granted
  19. US 10738030

    Modulators of cystic fibrosis transmembrane conductance regulator

    Vertex Pharmaceuticals Incorporated · Granted Aug 11, 2020 · Expires Aug 6, 2040

    granted
  20. US 10738009

    Pyridone amides as modulators of sodium channels

    Vertex Pharmaceuticals Incorporated · Granted Aug 11, 2020 · Expires Aug 6, 2040

    granted
  21. US 10738027

    Crystalline forms of C21H22Cl2N4O2

    Vertex Pharmaceuticals Incorporated · Granted Aug 11, 2020 · Expires Aug 6, 2040

    granted
  22. US 10738017

    Substituted triazoles and methods relating thereto

    Neurocrine Biosciences, Inc. · Granted Aug 11, 2020 · Expires Aug 6, 2040

    granted
  23. US 10737995

    Nuclear receptor modulators and their use for the treatment and prevention of cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 11, 2020 · Expires Aug 6, 2040

    granted
  24. US 10736976

    Radiolabeled anti-PD-L1 antibodies for immuno-PET imaging

    REGENERON PHARMACEUTICALS, INC. · Granted Aug 11, 2020 · Expires Aug 6, 2040

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.